BS en Iso 14730-2014
BS en Iso 14730-2014
BS en Iso 14730-2014
Ophthalmic optics —
Contact lens care products —
Antimicrobial preservative
efficacy testing and guidance
on determining discard date
BS EN ISO 14730:2014 BRITISH STANDARD
National foreword
This British Standard is the UK implementation of EN ISO
14730:2014. It supersedes BS EN ISO 14730:2000 which is withdrawn.
The UK participation in its preparation was entrusted to Technical
Committee CH/172/9, Contact lenses and contact lens care products.
A list of organizations represented on this committee can be
obtained on request to its secretary.
This publication does not purport to include all the necessary
provisions of a contract. Users are responsible for its correct
application.
© The British Standards Institution 2014. Published by BSI Standards
Limited 2014
ISBN 978 0 580 84870 4
ICS 11.040.70
Compliance with a British Standard cannot confer immunity from
legal obligations.
This British Standard was published under the authority of the
Standards Policy and Strategy Committee on 31 October 2014.
Amendments issued since publication
Date Text affected
EUROPEAN STANDARD EN ISO 14730
NORME EUROPÉENNE
EUROPÄISCHE NORM October 2014
English Version
CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this European
Standard the status of a national standard without any alteration. Up-to-date lists and bibliographical references concerning such national
standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN member.
This European Standard exists in three official versions (English, French, German). A version in any other language made by translation
under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management Centre has the same
status as the official versions.
CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United
Kingdom.
© 2014 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 14730:2014 E
worldwide for CEN national Members.
BS EN ISO 14730:2014
EN ISO 14730:2014 (E)
Foreword
This document (EN ISO 14730:2014) has been prepared by Technical Committee ISO/TC 172 “Optics and
photonics” in collaboration with Technical Committee CEN/TC 170 “Ophthalmic optics” the secretariat of which
is held by DIN.
This European Standard shall be given the status of a national standard, either by publication of an identical
text or by endorsement, at the latest by April 2015, and conflicting national standards shall be withdrawn at the
latest by April 2015.
Attention is drawn to the possibility that some of the elements of this document may be the subject of patent
rights. CEN [and/or CENELEC] shall not be held responsible for identifying any or all such patent rights.
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the following
countries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech
Republic, Denmark, Estonia, Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece,
Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal,
Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and the United Kingdom.
Endorsement notice
The text of ISO 14730:2014 has been approved by CEN as EN ISO 14730:2014 without any modification.
3
BS EN ISO 14730:2014
ISO 14730:2014(E)
Contents Page
Foreword......................................................................................................................................................................................................................................... iv
Introduction...................................................................................................................................................................................................................................v
1 Scope.................................................................................................................................................................................................................................. 1
2 Normative references....................................................................................................................................................................................... 1
3 Terms and definitions...................................................................................................................................................................................... 1
4 Principle......................................................................................................................................................................................................................... 1
5 Test methods.............................................................................................................................................................................................................. 2
5.1 Materials and reagents...................................................................................................................................................................... 2
5.2 Test sampling and culture maintenance............................................................................................................................ 2
5.3 Preparation of microbial challenge (Inoculum).......................................................................................................... 3
5.4 Inoculum challenge test procedure........................................................................................................................................ 3
5.5 Controls.......................................................................................................................................................................................................... 5
5.6 Performance criteria........................................................................................................................................................................... 5
5.7 Test report.................................................................................................................................................................................................... 6
Annex A (informative) Example of a membrane filtration procedure II.......................................................................... 7
Annex B (informative) Discard date procedure I...................................................................................................................................... 9
Annex C (informative) Discard date procedure.......................................................................................................................................12
Annex D (informative) Discard date procedure III..............................................................................................................................16
Annex E (informative) Discard date procedure IV...............................................................................................................................19
Annex F (informative) Test organisms from other culture collections...........................................................................22
Bibliography.............................................................................................................................................................................................................................. 23
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out
through ISO technical committees. Each member body interested in a subject for which a technical
committee has been established has the right to be represented on that committee. International
organizations, governmental and non-governmental, in liaison with ISO, also take part in the work.
ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of
electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are
described in the ISO/IEC Directives, Part 1. In particular the different approval criteria needed for the
different types of ISO documents should be noted. This document was drafted in accordance with the
editorial rules of the ISO/IEC Directives, Part 2 (see www.iso.org/directives).
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. ISO shall not be held responsible for identifying any or all such patent rights. Details of
any patent rights identified during the development of the document will be in the Introduction and/or
on the ISO list of patent declarations received (see www.iso.org/patents).
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation on the meaning of ISO specific terms and expressions related to conformity
assessment, as well as information about ISO’s adherence to the WTO principles in the Technical Barriers
to Trade (TBT) see the following URL: Foreword - Supplementary information
The committee responsible for this document is ISO/TC 172, Optics and photonics, Subcommittee
SC 7, Ophthalmic optics and instruments in collaboration with the Technical Committee CEN/TC 170,
Ophthalmic optics.
This second edition cancels and replaces the first edition (ISO 14730:2000), of which it constitutes a
minor revision.
Introduction
Contact lens care products (CLCP) are used with contact lenses. These products rinse, clean, disinfect,
store, wet, aid the comfort of, and condition contact lenses. Some products have one function, while
others are multifunctional.
Usually, products manufactured for use with hydrogel lenses may be used with rigid gas-permeable
(RGP) or poly (methyl methacrylate) (PMMA) lenses, but products specifically used for RGP or PMMA
contact lenses are not usually suitable for hydrogel lenses.
Most CLCPs are manufactured as solutions and are commonly packaged and sold in multidose containers.
Dry products are sold as tablets or granules and shall be dissolved in a suitable solvent immediately
prior to use.
If the contact lens care product solution does not have any antimicrobial activity itself, an antimicrobial
preservative can be added to the product to inhibit the growth of microorganisms that might be
introduced from repeated dispensing during use and subsequent storage. All antimicrobial agents
have the potential for toxicity to the user. For maximum protection to the user, the concentration of the
preservative should be such that it provides adequate preservative activity with minimum toxicity.
There are differences between ophthalmic preparations and contact lens care products and some
of these differences are significant in relation to preservative efficacy testing. Typically, ophthalmic
preparations are packaged in small-volume containers and are used for short periods on compromised
eyes. Contact lens care products are distributed in larger volume containers and are used with contact
lenses on a long term basis on healthy eyes. The potential risks for contact lens care products are the
solution/lens interaction causing ocular irritation and the risks of the solution contamination by the
repeated (daily) use of the product.
Thus, when contact lens care products are formulated, the risk of adverse patient reaction due to the
lens and/or solution interaction has to be weighed against the benefits of safety derived from the
maintenance of the antimicrobial activity of the solution.
This International Standard gives the test procedure and performance criteria for preservative efficacy.
It has been adapted from Pharmacopoeias which give a time limitation in their test procedure of 28 d.
The informative annexes give four examples of preservative efficacy test procedures developed by
contact lens care product manufacturers to show preservative efficacy for products whose discard
dates are over 28 d.
1 Scope
This International Standard specifies a procedure to be used in evaluating the antimicrobial preservative
activity of all preserved multidose contact lens care products, and provides guidance on methods for
determination of discard date as informative annexes.
This test is applicable to products for up to a 28-day discard date.
The test is not applicable to sterile products packaged in unit doses for single use or multidose containers
designed with physical barriers to microbial contamination (e.g. aerosol containers).
NOTE 1 Principles of the test can be used to extend discard dating beyond 28 d. See Annexes B, C, D and E.
NOTE 2 Use of multiple or mixed microbial challenges and/or inclusion of contact lenses or other organic
load can influence the apparent antimicrobial activity of a particular product. The evaluation of these variables
together with testing against a larger panel of microorganisms and testing of samples from partially used
containers can be of value in developing a contact lens care product, but are excluded from the scope of this
International Standard.
2 Normative references
The following documents, in whole or in part, are normatively referenced in this document and are
indispensable for its application. For dated references, only the edition cited applies. For undated
references, the latest edition of the referenced document (including any amendments) applies.
ISO 14534, Ophthalmic optics — Contact lenses and contact lens care products — Fundamental requirements
ISO 18369-1, Ophthalmic optics — Contact lenses — Part 1: Vocabulary, classification system and
recommendations for labelling specifications
4 Principle
4.1 The test consists of challenging the preparation with a specified inoculum of suitable microorganisms
at the commencement of the test and then rechallenging at day 14. The inoculated preparations are stored
at a specified temperature. Samples are withdrawn from the inoculated preparations at specified time
intervals and are cultured for determination of viable organisms. The capability of the product to prevent
re-growth is confirmed by counting of viable organisms over longer time periods.
4.2 The size of the microbial challenge chosen in this test is not intended to be representative of the
likely challenge in practice, but to provide countable numbers from which estimation of the rate and
extent of viability loss can be determined.
4.3 The antimicrobial preservative properties of the product are adequate if, in the conditions of the
test, there is significant reduction of bacteria and no increase in yeasts and moulds in the inoculated
preparation after the times and at the temperatures specified. The performance criteria are given in 5.6.
4.4 Appropriate measures shall be taken to inactivate or remove residual antimicrobial agents during
culturing and counting of survivors. The effectiveness of these measures shall be validated.
5 Test methods
5.1.2.3 Dulbecco’s Phosphate-Buffered Saline, without calcium chloride and magnesium chloride
(DPBS).
Combine 200 mg/l KCl, 200 mg/l KH2PO4, 8 000 mg/l NaCl, and 2 160 mg/l Na2HPO4 ⋅ 7H2O or
suitable diluent.
5.1.2.4 Dulbecco’s Phosphate Buffered Saline, plus 0,05 % volumic mass polysorbate 80 (DPBST) or
suitable diluent.
The following common laboratory equipment is required: sterile pipettes, swabs, tubes, petri dishes
(90 mm to 100 mm × 20 mm), etc. and suitable instruments for spectrophotometric determination of
cell density, for colony counting and for centrifugation.
Three lots of product shall be tested. Each lot of product shall be tested with a separate inoculum
preparation for each challenge organism.
Maintain the test cultures as recommended by the curator of the appropriate culture collection.
Cultures should be no greater than five passes removed from the depository stock (ATCC, NCIB, NCTC,
NCPF or other recognized culture depository; see Annex F). Each pass is a subculture of the previous pass.
Use sterile DPBST or suitable diluent to harvest each culture; wash the surface growth, transfer it to a
suitable vessel and vortex. Filter the spore suspensions through sterile glass wool, cheesecloth or gauze
to remove hyphal fragments.
After harvesting, the cultured organisms can be washed using centrifugation. The bacterial suspensions
can be filtered (e.g. 3 µm to 5 µm pore size) to produce a single cell dispersion. Then, adjust all challenge
cell suspensions with DPBST or other suitable diluent to a concentration of between 1,0 × 107 cfu/ml
and 1,0 × 108 cfu/ml. Estimate the approximate cell concentration of each suspension by measuring
the turbidity of the suspension or a dilution of the suspension using a spectrophotometer. The actual
concentration of colony-forming units per millilitre shall be determined for each suspension, e.g. by the
plate-count method, at the time of the test.
If centrifugation is used, each centrifugation should be conducted at 20 °C to 25 °C for no longer than the
equivalent of 10 min at 4 000 g or less.
Use bacterial and yeast cell suspensions on the day of preparation.
NOTE 1 Longer centrifugation times might be required at lower speeds.
NOTE 2 Spore suspensions can be used up to seven days following preparation by storage under refrigeration
(2 °C to 8 °C).
5.4.1 Prepare one or more tubes (for each lot tested) containing a minimum of 10 ml of test solution per
challenge organism.
NOTE Sample tubes are used rather than lens cases to allow effective technical execution of the test. Since
incompatibilities can exist between solution ingredients and tube materials, tubes of an appropriate material
which is compatible with the ingredients should be considered.
Inoculate the sample tube of the product to be tested with a suspension of test organisms sufficient
to provide a final count of between 1,0 × 105 cfu/ml and 1,0 × 106 cfu/ml. Ensure that the volume of
inoculum does not exceed 1 % of the sample volume. Ensure complete dispersion of the inoculum by
adequate mixing.
5.4.2 Store the inoculated product at 20 °C to 25 °C. The temperature shall be monitored using a
calibrated device and the temperature documented.
If the product is sensitive to light, it should be protected during the period of the test.
5.4.3 Take 1,0 ml aliquots of the inoculated product for determination of viable count at 7 d and 14 d.
5.4.4 After taking the 14 d sample, each sample is rechallenged as in 5.4.1 by using an inoculum level of
1,0 × 104 cfu/ml to 1,0 × 105 cfu/ml.
5.4.5 Take 1,0 ml aliquots of the inoculated product for determination of the viable count at 21 d and 28 d.
5.4.6 Subject each of the 1,0 ml aliquots, removed at the specified time intervals, to a suitable series of
decimal dilutions in validated neutralizing media. Mix the suspension well by vortexing vigorously and
let stand to allow neutralization to be completed. Neutralization conditions shall be based on recovery-
medium control testing (see 5.5.2).
5.4.7 Determine the viable count of organisms in appropriate dilutions by preparation of triplicate plates
(unless otherwise justified) of a suitable recovery medium (e.g. TSA for bacteria and SDA for mould and yeast).
If membrane filtration has been employed to remove or neutralize antimicrobial agents, culture the
membranes on these media as appropriate.
If the pour-plate method is utilized, keep the agar for pour plates below 50 °C prior to pouring.
NOTE The agar media used for determination of viable counts can also contain antimicrobial inactivators or
neutralizers, if required.
5.4.8 Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to
25 °C or 30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Incubation times for optimal
recovery of bacteria, yeast, and moulds shall be determined. Minimum incubation times shall be based on
recovery medium control testing (see 5.5.2). Record the number of cfu observed on countable plates.
Plates should be observed periodically during incubation to prevent the occurrence of uncountable
plates due to overgrowth.
5.4.9 Determine the average number of colony-forming units on countable plates. Calculate the
microbial reduction at the specified time points.
NOTE Countable plates refer to 30 cfu to 300 cfu per plate for bacteria and yeast, and 8 cfu to 80 cfu per plate
for moulds, except when colonies are observed only for the 100 or 10−1 dilution plates.
5.4.10 The absence of microorganisms shall be documented, e.g. by recording a “0” or “NR” (no recovery),
when plates for all dilutions of a sample at a single time point have zero colonies.
5.4.11 The concentration of survivors is calculated at each point of time. The concentration of viable
organisms following the 14 d rechallenge is the sum of the rechallenge inoculum concentration and the
14 d survivor concentration.
5.5 Controls
The initial and rechallenge inoculum concentrations are calculated by dispersing an identical aliquot of
the inoculum into the same volume as used in 5.4.1 of a suitable diluent to achieve a final concentration
not less than 1,0 × 105 cfu/ml to 1,0 × 106 cfu/ml for the initial inoculum or 1,0 × 104 cfu/ml to
1,0 × 105 cfu/ml for the rechallenge. The volume of inoculum does not exceed 1 % of the sample volume.
Ensure dispersion of the inoculum by adequate mixing. Evaluate this control sample for cfu/ml at the
beginning of the test in order to demonstrate the suitability of the medium used for growth of the test
organism and provide an estimate of the initial inoculum concentration. Plate the appropriate aliquot
from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Vortex a 1/10 dilution of the preserved product in the validated neutralizing broth (1 ml into 9 ml). Let
it stand to allow neutralization to be completed. Prepare a second control tube with 10 ml of a suitable
diluent (e.g. DPBST). Inoculate the tubes with sufficient inoculum to result in 10 cfu to 100 cfu of challenge
organism per plate. Incubate for an appropriate period of time at ambient temperature. Plate the
appropriate aliquot from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to 25 °C or
30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Determine minimum incubation times
for optimal recovery of bacteria, yeast, and moulds.
Check that the recovery from the neutralizer broth is at least 50 % of the recovery in the second control
tube. Perform this control for each challenge organism.
If a dilution of greater than 1/10 is required for neutralization, then membrane filtration should be used.
Validate the neutralization of the product with each challenge organism initially and as appropriate.
5.6.1 General
Products shall be capable of meeting these criteria throughout their labelled shelf life and at the discard date.
Meeting the criteria of 5.6.2 and 5.6.3 shall justify a 28 d period of use after opening (discard date).
NOTE Refer to Annexes B, C, D and E for suggested methods if a discard date longer than 28 d is desired.
5.6.2 Bacteria
The number of each challenge organism recovered per millilitre shall be reduced by a mean value of not
less than 3,0 logs at 14 d. After the rechallenge at 14 d, the concentration of each challenge organism
shall be reduced again by at least a mean value of 3,0 logs by 28 d.
The number of each challenge organism recovered per millilitre shall remain at, or below, the initial
concentrations (within an experimental error of ±0,5 logs) within 14 d. At 28 d, the concentration of each
challenge organism shall remain at, or below, the concentrations (within an experimental error of ±0,5
logs) of each challenge organism after the rechallenge.
Annex A
(informative)
A.1.1.3 Dulbecco’s Phosphate-Buffered Saline, without calcium chloride and magnesium chloride
(DPBS): 200 mg/l KCl, 200 mg/l KH2PO4, 8 000 mg/l NaCl, and 2 160 mg/l Na2HPO4⋅7H2O or suitable diluent.
A.1.1.4 Dulbecco’s Phosphate-Buffered Saline, plus 0,05 % polysorbate 80 (DPBST) or suitable diluent.
A.1.2.2 Suitable sterile apparatus, for holding the sterile membrane filter and filtrate.
A.1.2.3 Suitable equipment for creating a vacuum or pressure, to cause the liquid phase of the
inoculated test solution to pass through the membrane filter aseptically.
The membrane filter should have a nominal pore size of not greater than 0,45 µm, a diameter of at least
47 mm and should be free of chemicals which could be toxic to microbial cells.
A.2.1 Moisten the sterile membrane filter (A.1.2.1) in a sterile filter assembly (A.1.2.2) with sterile
DPBST (A.1.1.4), or suitable diluent.
A.2.2 Aseptically transfer a measured volume of the inoculated test solution into sterile DPBST (A.1.1.4)
or diluting fluid.
A.2.3 Transfer the diluted solution to the membrane and filter immediately with the aid of vacuum or
pressure. Dilute the sample applied to the filter with 50 ml to 100 ml of dilution fluid and thoroughly mix
to ensure uniform distribution of the sample over the entire area of the filter.
NOTE This will decrease the probability of multiple colony-forming units being placed on the filter at the
same location.
A.2.4 Wash the membrane filter with several volumes of diluting fluid which may contain additional
neutralizing agents as needed. The actual volume should be determined empirically for each formulation
for each challenge organism.
NOTE Three volumes of diluting fluid (100 ml each) are usually sufficient to remove and/or dilute the
antimicrobial agent.
A.2.5 Incubate the membrane filter with appropriate media to allow growth of colony-forming units on
the surface of the filter.
This can be accomplished by aseptic removal of the membrane filter from the filter assembly unit and
placement of the membrane on the surface of a sterile agar plate which does not have obvious liquid on
the surface; or the membrane can be enclosed in an agar sandwich. Alternatively, a sterile membrane
filter unit can be used which requires addition of sterile media to the sealed filter and incubation of the
membrane in situ. Media should be used which are appropriate for the type of challenge organism and
the specific formulation under test. Time of the incubation should be established.
A.2.6 Determine the average number of colony-forming units on the countable membrane filters (3 cfu
to 100 cfu/47 mm filter for bacteria and yeast and 3 cfu to 10 cfu/47 mm filter for moulds). Calculate and
document the number of colony-forming units per millilitre of inoculated solution.
A.3 Controls
Confirm neutralizer efficacy by transferring an aliquot of the uninoculated test solution into 50 ml to
100 ml of sterile diluting fluid using the same ratio of volume of test solution to volume of diluting fluid.
Apply the entire volume to the membrane and filter using vacuum or pressure. Wash the filter with several
volumes of the diluting fluid using the same volume as used for the test procedure. Transfer 5 cfu to 100 cfu
challenge organisms (one species per filter) into 100 ml of diluting fluid and apply to the membrane.
Incubate the membrane filter in contact with media as described in the test procedure (see A.2.5).
Repeat the procedure using diluting fluid not exposed to the test solution. Compare counts with those
derived by the same method but using a suitable diluent (e.g. DPBST), instead of the test solution. Confirm
the inoculum on a suitable medium in triplicate (unless otherwise justified). Ensure that the recovery in
the neutralizer broth is at least 50 % of the inoculum.
Annex B
(informative)
B.1 Principle
B.1.1 The test consists of inoculating the test samples with a high level of organism (approximately
106 cfu/ml) on 0 d. The test samples are rechallenged with a low organism inoculum level (approximately
103 cfu/ml) in the test formulation.
B.1.2 Inoculation times are at initial, 2 weeks, 25 %, 50 %, 75 %, and 100 % of the proposed discard date.
B.1.3 Sampling times should include 1 week, 2 weeks, 3 weeks, 4 weeks, and 25 %, 50 %, 75 %, and
100 % of the proposed discard date, and 14 d after the proposed discard date.
B.1.4 Test samples should meet the test criteria for ISO Preservative Efficacy of Multidose Preserved
Contact Lens Care Products at 28 d.
Challenge tests are conducted to support discard after opening date, using three lots of contact lens care
solutions representative of the product to be marketed.
Culture maintenance should be as specified in 5.2.
B.2.3.1 Prepare a composite sample of greater than 250 ml from individual test samples.
B.2.3.2 Prepare a separate 50 ml quantity of test formulation for each test organism. Place the sample
into a 250 ml flask or specimen container.
B.2.3.3 Prepare 50 ml containers of a suitable diluent for bacteria, yeast, and mould controls.
B.2.3.4 Inoculate formulation samples and controls with 0,5 ml aliquot of the 108 cfu/ml organism
suspension to achieve a final concentration of approximately 106 cfu/ml. Ensure complete dispersion of
the inoculum by adequate mixing.
B.2.3.5 Store the inoculated product at 20 °C to 25 °C. The temperature shall be monitored using a
calibrated device and the temperature documented.
If the contact lens care product is sensitive to light, it should be protected during the period of the test.
B.2.3.6 At 1 week, 2 weeks, 3 weeks, 4 weeks, and at 25 %, 50 %, 75 %, and 100 % of the proposed
discard date, and 14 d after the proposed discard date, take 1,0 ml aliquots of the inoculated product for
determination of viable counts.
B.2.3.7 Rechallenge the formulation samples at 2 weeks, 25 %, 50 %, 75 %, and 100 % of the proposed
discard date, using a 0,05 ml/50 ml ratio of a 106 cfu/ml organism suspension to provide a final
concentration of approximately 103 cfu/ml. Repeat the viable count determinations at each time point
prior to rechallenging.
B.2.3.8 Subject each of the 1,0 ml aliquots, removed at the specified time intervals, to a suitable series
of decimal dilutions in validated neutralizing media. Mix the suspension well by vortexing vigorously and
let stand to allow neutralization to be completed.
B.2.3.9 Determine the viable count of organisms in appropriate dilutions by preparation of plates in
triplicate (unless otherwise justified) of a suitable recovery medium (e.g. TSA for bacteria and SDA for
mould and yeast).
If membrane filtration has been employed to remove or neutralize antimicrobial agents, culture the
membranes on these media as appropriate.
If the pour-plate method is utilized, keep the agar for pour plates below 50 °C prior to pouring.
NOTE The agar media used for determination of viable counts may also contain antimicrobial inactivators or
neutralizers, if required.
B.2.3.10 Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to
25 °C or 30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Incubation times for optimal
recovery of bacteria, yeast and moulds should be determined. Minimum incubation times should be based
on recovery medium control testing (see B.2.4.2).
B.2.3.11 Determine the average number of colony-forming units on countable plates. Calculate the
microbial reduction at the specified time points.
NOTE Countable plates refer to 30 cfu to 300 cfu/plate for bacteria and yeast, and 8 cfu to 80 cfu/plate for
moulds, except when colonies are observed only for the 100 or 10−1 dilution plates.
B.2.3.12 When plates for all dilutions of a sample at a single time point indicate no recovery of
microorganisms, it should be documented.
B.2.4 Controls
Fresh control samples are run at each inoculation date by inoculating the saline (for bacteria and yeast)
or saline/Tween®1) 80 for mould in the same manner as for the sample inoculation. The theoretical
numbers can be found by calculating the cumulative sum of the last inoculum, plus the last survivor
count in the formulation sample.
Vortex a 1/10 dilution of the preserved product in the validated neutralizing broth (1 ml into 9 ml). Let
it stand to allow neutralization to be completed. Prepare a second control tube with 10 ml of a suitable
diluent (e.g. DPBST). Inoculate the tubes with sufficient inoculum to result in 10 cfu to 100 cfu of challenge
organism per plate. Incubate for an appropriate period of time at ambient temperature. Plate the
appropriate aliquot from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to 25 °C or
30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Determine minimum incubation times
for optimal recovery of bacteria, yeast, and moulds.
Check that the recovery in the neutralizer broth is at least 50 % of the recovery in the second control
tube. Perform this control for each challenge organism.
If a dilution of greater than 1/10 is required for neutralization, then membrane filtration shall be used.
Qualify the neutralization of the product initially and periodically.
1) Tween is an example of a suitable product available commercially. This information is given for the convenience
of users of this International Standard and does not constitute an endorsement by ISO of this product.
2) The number of organisms recovered from a test sample does not exceed the sum of the microbial counts from
the inoculation plus the last count of survivors within a ±0,5 log variance (i.e. multiplication of the organisms did not
occur).
Annex C
(informative)
C.1 Principle
C.1.1 The test consists of challenging the preparation with a specified inoculum of suitable
microorganisms, storing the inoculated preparation at a specified temperature, withdrawing samples
from the container at specified time intervals, and counting the organisms in the samples removed. The
capability of the product to prevent re-growth is confirmed by counting of viable organisms over longer
time periods.
C.1.2 The size of the microbial challenge chosen in this test is not intended to be representative of the
likely challenge in practice, but to provide countable numbers from which estimation of the rate and
extent of viability loss can be determined.
C.1.3 The preparation shall meet the requirements for an adequately preserved contact lens care
product initially, and following a simulated use for the intended discard date interval (performance
criteria are included in C.2.7).
C.1.4 Appropriate measures should be taken to inactivate or remove residual antimicrobial agents
during culturing and counting of survivors, and the effectiveness of these measures should be validated.
The action of this process during the test should be demonstrated by the construction of suitable controls.
The contact lens care product to be tested should be representative of the product to be marketed. Three
lots of product should be tested. Aliquots should be taken directly from the final product container
immediately prior to testing. A suitable number of containers should be utilized to ensure that enough
product will be available for challenge testing after simulated use (i.e. containers can be pooled in order
to provide sufficient product for testing).
Culture maintenance should be as specified in 5.2.
C.2.3.1 Prepare one tube containing a minimum of 10 ml of test solution per challenge organism.
Inoculate the sample tube of the product to be tested with a suspension of test organisms sufficient
to provide a final count of between 1,0 × 105 cfu/ml and 1,0 × 106 cfu/ml. Ensure that the volume of
inoculum does not exceed 1 % of the sample volume. Ensure complete dispersion of the inoculum by
adequate mixing.
C.2.3.2 Store the inoculated product at 20 °C to 25 °C. The temperature shall be monitored using a
calibrated device and the temperature documented.
If the contact lens care product is sensitive to light, it should be protected during the period of the test.
C.2.3.3 Take 1,0 ml aliquots of the inoculated product for determination of viable count at 7 d and 14 d.
C.2.3.4 After taking the 14 d sample, each sample is rechallenged as in C.2.3.1 by using an inoculum
level of 1,0 × 104 cfu/ml to 1,0 × 105 cfu/ml.
C.2.3.5 Take 1,0 ml aliquots of the inoculated product for determination of the viable count at 21 d and 28 d.
C.2.3.6 Subject each of the 1,0 ml aliquots, removed at the specified time intervals, to a suitable series
of decimal dilutions in validated neutralizing media. Mix the suspension well by vortexing vigorously and
let stand to allow neutralization to be completed.
C.2.3.7 Determine the viable count of organisms in appropriate dilutions by preparation of plates in
triplicate (unless otherwise justified) of a suitable recovery medium (e.g. TSA for bacteria and SDA for
mould and yeast).
If membrane filtration has been employed to remove or neutralize antimicrobial agents, culture the
membranes on these media as appropriate.
If the pour-plate method is utilized, keep the agar for pour plates below 50 °C prior to pouring.
NOTE The agar media used for determination of viable counts may also contain antimicrobial inactivators or
neutralizers, if required.
C.2.3.8 Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to
25 °C or 30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Incubation times for optimal
recovery of bacteria, yeast, and moulds should be determined. Minimum incubation times should be
based on recovery medium control testing (see C.2.6.2).
C.2.3.9 Determine the average number of colony-forming units on countable plates. Calculate the
microbial reduction at the specified time points.
NOTE Countable plates refer to 30 cfu to 300 cfu/plate for bacteria and yeast, and 8 cfu to 80 cfu/plate for
moulds, except when colonies are observed only for the 100 or 10−1 dilution plates.
C.2.3.10 When plates for all dilutions of a sample at a single time point indicate no recovery of
microorganisms, it should be documented.
C.2.3.11 The concentration of survivors is calculated at each time point. The concentration of viable
organisms following the 14 d rechallenge is the sum of the rechallenge inoculum concentration and the
14 d survivor concentration.
C.2.6 Controls
The initial and rechallenge inoculum concentrations are calculated by dispersing an identical aliquot of
the inoculum into the same volume of a suitable diluent used in C.2.3.1 to achieve a final concentration of
not less 1,0 × 105 cfu/ml to 5,0 × 106 cfu/ml for the initial inoculum or 1,0 × 104 cfu/ml to 1,0 × 105 cfu/ml
for the rechallenge. The volume of inoculum shall not exceed 1 % of the sample volume. Ensure dispersion
of the inoculum by adequate mixing. Evaluate this control sample for colony-forming units per millilitre
at the beginning of the test, in order to demonstrate the suitability of the medium used for growth of
the test organism and provide an estimate of the initial inoculum concentration. Plate the appropriate
aliquot from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Vortex a 1/10 dilution of the preserved product in the validated neutralizing broth (1 ml into 9 ml). Let
it stand to allow neutralization to be completed. Prepare a second control tube with 10 ml of a suitable
diluent (e.g. DPBST). Inoculate the tubes with sufficient inoculum to result in 10 cfu to 100 cfu of challenge
organism per plate. Incubate for an appropriate period of time at ambient temperature. Plate the
appropriate aliquot from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to 25 °C or
30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Determine minimum incubation times
for optimal recovery of bacteria, yeast, and moulds.
Check that the recovery in the neutralizer broth is at least 50 % of the recovery in the second control
tube. Perform this control for each challenge organism.
If a dilution of greater than 1/10 is required for neutralization, then membrane filtration shall be used.
Qualify the neutralization of the product initially and periodically.
C.2.7.1 General
Products shall meet the performance criteria for both the initial challenge and the final challenge
following simulated use.
C.2.7.2 Bacteria
The number of organisms recovered per millilitre should be reduced by a value of not less than 3,0 logs
at 14 d. After the rechallenge at 14 d, the concentration of bacteria should be reduced again by at least
a mean value of 3,0 logs by 28 d.
The number of organisms recovered per millilitre should remain at, or below, the initial concentrations
(within an experimental error of ±0,5 logs) within 14 d. At 28 d, the concentration of moulds and yeast
should remain at, or below, the concentrations (within an experimental error of ±0,5 logs) of moulds and
yeasts after the rechallenge.
Annex D
(informative)
D.1 Principle
D.1.1 The test consists of challenging the preparation with a specified inoculum of suitable
microorganisms, storing the inoculated preparation at a specified temperature, withdrawing samples
from the container at specified time intervals, and counting the organisms in the samples removed. The
capability of the product to prevent re-growth is confirmed by counting of viable organisms over longer
time periods.
D.1.2 The size of the microbial challenge chosen in this test is not intended to be representative of the
likely challenge in practice, but to provide countable numbers from which estimation of the rate and
extent of viability loss can be determined.
D.1.3 The preparation shall meet the requirements for an adequately preserved contact lens care
product throughout its intended discard date period (for performance criteria see D.2.5).
D.1.4 Appropriate measures should be taken to inactivate or remove residual antimicrobial agents
during culturing and counting of survivors, and the effectiveness of these measures should be validated.
The action of this process during the test should be demonstrated by the construction of suitable controls.
The contact lens care product to be tested should be representative of the product to be marketed.
Three lots of product should be tested. Testing should be conducted in the actual product container. The
largest container size proposed for the product should be utilized.
Culture maintenance should be as specified in 5.2.
D.2.3.1 Inoculate the sample product to be tested with a suspension of test organisms sufficient
to provide a final count of between 1,0 × 105 cfu/ml and 1,0 × 106 cfu/ml. Ensure that the volume of
inoculum does not exceed 1 % of the sample volume. Ensure complete dispersion of the inoculum by
adequate mixing.
D.2.3.2 Store the inoculated product at 20 °C to 25 °C. The temperature shall be monitored using a
calibrated device and the temperature documented.
If the contact lens care product is sensitive to light, it should be protected during the period of the test.
D.2.3.3 Take 1,0 ml aliquots of the inoculated product for determination of viable count at 7 d, 14 d,
21 d, and 28 d, and continue sampling at 7 d intervals until the product contents are depleted.
D.2.3.4 Subject each of the 1,0 ml aliquots, removed at the specified time intervals, to a suitable series
of decimal dilutions in validated neutralizing media. Mix the suspension well by vortexing vigorously and
let stand to allow neutralization to be completed.
D.2.3.5 Determine the viable count of organisms in appropriate dilutions by preparation of plates in
triplicate (unless otherwise justified) of a suitable recovery medium (e.g. TSA for bacteria and SDA for
mould and yeast).
If membrane filtration has been employed to remove or neutralize antimicrobial agents, culture the
membranes on these media as appropriate.
If the pour-plate method is utilized, keep the agar for pour plates below 50 °C prior to pouring.
NOTE The agar media used for determination of viable counts may also contain antimicrobial inactivators or
neutralizers, if required.
D.2.3.6 Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to
25 °C or 30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Incubation times for optimal
recovery of bacteria, yeast, and moulds should be determined. Minimum incubation times should be
based on recovery medium control testing (see D.2.4.2).
D.2.3.7 Determine the average number of colony-forming units on countable plates. Calculate the
microbial reduction at the specified time points.
NOTE Countable plates refer to 30 cfu to 300 cfu/plate for bacteria and yeast, and 8 cfu to 80 cfu/plate for
moulds, except when colonies are observed only for the 100 or 10−1 dilution plates.
D.2.3.8 When plates for all dilutions of a sample at a single time point indicate no recovery of
microorganisms, it should be documented.
D.2.4 Controls
The initial inoculum concentration is calculated by dispersing an identical aliquot of the inoculum
into the same volume of a suitable diluent used in D.2.3.1 to achieve a final concentration not less than
1,0 × 104 cfu/ml to 5,0 × 105 cfu/ml. The volume of inoculum does not exceed 1 % of the sample volume.
Ensure dispersion of the inoculum by adequate mixing. Evaluate this control sample for cfu/ml at the
beginning of the test in order to demonstrate the suitability of the medium used for growth of the test
organism and provide an estimate of the initial inoculum concentration. Plate the appropriate aliquot
from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Vortex a 1/10 dilution of the preserved product in the validated neutralizing broth (1 ml into 9 ml). Let
it stand to allow neutralization to be completed. Prepare a second control tube with 10 ml of a suitable
diluent (e.g. DPBST). Inoculate the tubes with sufficient inoculum to result in 10 cfu to 100 cfu of challenge
organism per plate. Incubate for an appropriate period of time at ambient temperature. Plate the
appropriate aliquot from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to 25 °C or
30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Determine minimum incubation times
for optimal recovery of bacteria, yeast, and moulds.
Check that the recovery in the neutralizer broth is at least 50 % of the recovery in the second control
tube. Perform this control for each challenge organism.
If a dilution of greater than 1/10 is required for neutralization, then, membrane filtration shall be used.
Qualify the neutralization of the product initially and periodically.
The number of organisms recovered per millilitre should remain at, or below, the initial concentrations.
The product discard date should correspond to the interval prior to a time point which reveals an
increase in number for any organism.
EXAMPLE See Table D.1.
Table D.1
Count at day
Organism
0 7 14 21 28 35
E.coli 105 101 102 102 103 103
P. aeruginosa 105 103 103 102 103 104
S. aureus 105 <10 <10 <10 <10 <10
C. albicans 105 105 104 102 <10 <10
A. brasiliensis 105 104 103 104 104 105
NOTE 1 Interval prior to time point which reveals an increase in growth:
E. coli: 7 d
P. aeruginosa: 21 d
A. brasiliensis: 14 d
NOTE 2 The discard date in the above hypothetical product is 7 d after opening.
Annex E
(informative)
E.1 Principle
E.1.1 The test consists of inoculating product bottles with a low level of organisms. The test samples are
repeatedly rechallenged with a low level of organisms inoculated into the product bottle according to schedule.
E.1.2 Inoculation times are at initial, 24 h, 1 week, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks,
16 weeks, 18 weeks, 24 weeks and further at 6-week intervals and/or until twice the desired or labelled
discard date is reached.
E.1.3 Sampling times begin at 24 h and immediately before each rechallenge and at the end point of the test.
E.1.4 To pass the test, all sample point counts shall be less than the total of the most recent challenge
plus the previous survivor count.
Challenge tests are conducted directly into final product containers. A minimum of two sample containers for
each test organism, from each of three individual product lots representative of the product to be marketed,
are selected for testing at each interval in the stability-testing schedule selected for discard dating.
Culture maintenance should be as specified in 5.2.
E.2.3.1 On day 0, inoculate a series of the final product containers being tested with a single strain
of test organisms suspended to a level to produce a 1,0 × 103 cfu/ml to 2,0 × 103 cfu/ml count in the
volume of product being tested. The volume of inoculum should not exceed 0,5 % of the sample volume at
each challenge period, to reduce the risk of diluting the test product sample over repeated rechallenges.
Ensure dispersion of inoculum by adequate mixing.
E.2.3.2 Store the inoculated product at 20 °C to 25 °C. The temperature shall be monitored using a
calibrated device and the temperature documented.
If the contact lens care product is sensitive to light, it should be protected during the period of the test.
E.2.3.3 At 24 h, take 1,0 ml aliquots of the inoculated product for determination of viable counts.
E.2.3.4 Rechallenge with fresh cultures of the same inoculum organism, level and quantity as in E.2.3.1,
store at 20 °C to 25 °C until day 7 and repeat the viable count determination, rechallenge, and storage
steps. Duplicate this process at 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 18 weeks, 24 weeks and as
needed at 6-week intervals, and/or until two times the desired or labelled discard date has been reached.
E.2.3.5 Subject each of the 1,0 ml aliquots, removed at the specified time intervals, to a suitable series
of decimal dilutions in validated neutralizing media. Mix the suspension well by vortexing vigorously and
let stand to allow neutralization to be completed.
E.2.3.6 Determine the viable count of organisms in appropriate dilutions by preparation of plates in
triplicate (unless otherwise justified) of a suitable recovery medium (e.g. TSA for bacteria and SDA for
mould and yeast).
If membrane filtration has been employed to remove or neutralize antimicrobial agents, culture the
membranes on these media as appropriate.
If the pour-plate method is utilized, keep the agar for pour plates below 50 °C prior to pouring.
NOTE The agar media used for determination of viable counts may also contain antimicrobial inactivators or
neutralizers, if required.
E.2.3.7 Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20° C to
25 °C or 30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Incubation times for optimal
recovery of bacteria, yeast, and moulds should be determined. Minimum incubation times should be
based on recovery medium control testing (see E.2.4.2).
E.2.3.8 Determine the average number of colony-forming units on countable plates. Calculate the
microbial reduction at the specified time points.
NOTE Countable plates refer to 30 cfu to 300 cfu/plate for bacteria and yeast, and 8 cfu to 80 cfu/plate for
moulds, except when colonies are observed only for the 100 or 10−1 dilution plates.
E.2.3.9 When plates for all dilutions of a sample at a single time point indicate no recovery of
microorganisms, it should be documented.
E.2.4 Controls
At each time interval duplicate matched bottles containing a suitable diluent (e.g. DPBST) are inoculated
at the same time as the test samples for the determination of inoculum levels. The volume in the control
container should approximate the remaining volume in the test container. Ensure dispersion of the
inoculum by adequate mixing. Evaluate this control sample for cfu/ml at the beginning of the test in
order to demonstrate the suitability of the medium used for growth of the test organism and provide
an estimate of the initial inoculum concentration. Plate the appropriate aliquot from each tube onto the
recovery agar plates in triplicate (unless otherwise justified).
Vortex a 1/10 dilution of the preserved product in the validated neutralizing broth (1 ml into 9 ml). Let
it stand to allow neutralization to be completed. Prepare a second control tube with 10 ml of a suitable
diluent (e.g. DPBST). Inoculate the tubes with sufficient inoculum to result in 10 cfu to 100 cfu of challenge
organism per plate. Incubate for an appropriate period of time at ambient temperature. Plate the
appropriate aliquot from each tube onto the recovery agar plates in triplicate (unless otherwise justified).
Incubate bacterial recovery plates at 30 °C to 35 °C. Incubate yeast recovery plates at 20 °C to 25 °C or
30 °C to 35 °C. Incubate mould recovery plates at 20 °C to 25 °C. Determine minimum incubation times
for optimal recovery of bacteria, yeast, and moulds.
Check that the recovery in the neutralizer broth is at least 50 % of the recovery in the second control
tube. Perform this control for each challenge organism.
If a dilution of greater than 1/10 is required for neutralization, then membrane filtration shall be used.
Qualify the neutralization of the product initially and periodically.
E.2.5.1 The test is carried out to two times the desired or labelled discard time.
E.2.5.2 The numbers of organisms recovered should not be more than the sum of the most recent
inoculum plus the previous survivor count within a ±0,5 log variance, (i.e. multiplication of organisms
has not occurred).
E.2.5.3 The products should be capable of meeting these criteria throughout the labelled shelf life and
for the additional time of the discard-after-opening date at the end of the shelf life.
Annex F
(informative)
Bibliography
[1] Ph. Eur. 1994. Efficacy of antimicrobial preservation. In: European Pharmacopoeia 1994, 2nd ed.,
Part 11, 18th section. Maisonneuve S.A., Sainte-Ruffine, France, p.V111.14.1-V111.14.4
[2] USP 23. 1994. Antimicrobial preservatives — Effectiveness. In United States Pharmacopoeia,
23rd rev. U.S. Pharmacopoeial Convention, Inc., Rockville, MD, p. 1681
[3] Urban/Hecker/Schiller. Analytical R & D Sandoz AG, Basel. Zbl. Bakt. Hyg. I. Abt. A. 1981,
172 pp. 478–484
About us Revisions
We bring together business, industry, government, consumers, innovators Our British Standards and other publications are updated by amendment or revision.
and others to shape their combined experience and expertise into standards We continually improve the quality of our products and services to benefit your
-based solutions. business. If you find an inaccuracy or ambiguity within a British Standard or other
The knowledge embodied in our standards has been carefully assembled in BSI publication please inform the Knowledge Centre.
a dependable format and refined through our open consultation process.
Organizations of all sizes and across all sectors choose standards to help Copyright
them achieve their goals. All the data, software and documentation set out in all British Standards and
other BSI publications are the property of and copyrighted by BSI, or some person
Information on standards or entity that owns copyright in the information used (such as the international
We can provide you with the knowledge that your organization needs standardization bodies) and has formally licensed such information to BSI for
to succeed. Find out more about British Standards by visiting our website at commercial publication and use. Except as permitted under the Copyright, Designs
bsigroup.com/standards or contacting our Customer Services team or and Patents Act 1988 no extract may be reproduced, stored in a retrieval system
Knowledge Centre. or transmitted in any form or by any means – electronic, photocopying, recording
or otherwise – without prior written permission from BSI. Details and advice can
Buying standards be obtained from the Copyright & Licensing Department.
You can buy and download PDF versions of BSI publications, including British
and adopted European and international standards, through our website at Useful Contacts:
bsigroup.com/shop, where hard copies can also be purchased. Customer Services
If you need international and foreign standards from other Standards Development Tel: +44 845 086 9001
Organizations, hard copies can be ordered from our Customer Services team. Email (orders): [email protected]
Email (enquiries): [email protected]
Subscriptions
Subscriptions
Our range of subscription services are designed to make using standards
Tel: +44 845 086 9001
easier for you. For further information on our subscription products go to
Email: [email protected]
bsigroup.com/subscriptions.
With British Standards Online (BSOL) you’ll have instant access to over 55,000 Knowledge Centre
British and adopted European and international standards from your desktop. Tel: +44 20 8996 7004
It’s available 24/7 and is refreshed daily so you’ll always be up to date. Email: [email protected]
You can keep in touch with standards developments and receive substantial
Copyright & Licensing
discounts on the purchase price of standards, both in single copy and subscription
format, by becoming a BSI Subscribing Member. Tel: +44 20 8996 7070
Email: [email protected]
PLUS is an updating service exclusive to BSI Subscribing Members. You will
automatically receive the latest hard copy of your standards when they’re
revised or replaced.
To find out more about becoming a BSI Subscribing Member and the benefits
of membership, please visit bsigroup.com/shop.
With a Multi-User Network Licence (MUNL) you are able to host standards
publications on your intranet. Licences can cover as few or as many users as you
wish. With updates supplied as soon as they’re available, you can be sure your
documentation is current. For further information, email [email protected].